Target intelligence / Profile preview

Novel transcript, antisense to GRAMD3 (ENSG00000250602)

Target: ENSG00000250602
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

ENSG00000250602 is a long non-coding RNA (lncRNA) transcribed antisense to the GRAMD3 gene, overlapping this region on chromosome 5. Antisense transcripts such as this one frequently serve regulatory roles, potentially influencing the chromatin state and transcriptional output of the overlapping sense gene (GRAMD3) by mechanisms that include transcriptional interference, RNA masking, formation of double-stranded RNA, or local chromatin remodeling. However, for this particular transcript, no specific biological function, mechanism, or disease association is currently established in public databases, and it is not considered a protein-coding gene nor a canonical therapeutic target at this time.

Other names: Ensembl transcript IDsGRAMD3-AS lncRNA

Mechanism of action

Not applicable; no drugs target this molecule.

Biological functions

Regulation of gene expression (putative, inferred from antisense lncRNA function across the genome)Possible role in epigenetic control or transcriptional interference (general to antisense lncRNAs)

Beyond the preview

Go deeper on Novel transcript, antisense to GRAMD3 (ENSG00000250602).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to GRAMD3 (ENSG00000250602).

Explore the full profile